These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
90 related articles for article (PubMed ID: 1139228)
41. Antihypertensive agents in renal disease. White RP Am J Med; 1977 Apr; 62(4):539-41. PubMed ID: 851127 [No Abstract] [Full Text] [Related]
42. Effects of the nonapeptide SQ 20.881 on the blood pressure of conscious normotensive and chronic hypertensive mice. Svendsen UG Acta Pathol Microbiol Scand A; 1977 Nov; 85(6):942-4. PubMed ID: 602780 [TBL] [Abstract][Full Text] [Related]
43. Outpatient experience with saralasin. Streeten DH; Anderson GH Kidney Int Suppl; 1979 Mar; (9):S44-52. PubMed ID: 289863 [No Abstract] [Full Text] [Related]
44. Editorial: Diagnosis of renovascular hypertension. Am Fam Physician; 1976 Mar; 13(3):71. PubMed ID: 1258718 [No Abstract] [Full Text] [Related]
45. The immediate pressor response to saralasin: a measure of the degree of angiotensin II vascular receptor vacancy. Wallace JM; Case DB; Laragh JH; Sealey JE; Keim HJ; Drayer JI Trans Assoc Am Physicians; 1977; 90():300-12. PubMed ID: 205983 [TBL] [Abstract][Full Text] [Related]
46. Depressor effect of saralasin in hypertensive crisis due to pheochromocytoma. Röckel A; Heidland A; Appel E; Palm D N Engl J Med; 1977 Jan; 296(1):50-1. PubMed ID: 830274 [No Abstract] [Full Text] [Related]
47. [Various inhbitors of the renin-angiotensin system and their clinical use]. Bar-Andziak E Pol Arch Med Wewn; 1979 Jan; 61(1):69-74. PubMed ID: 370806 [No Abstract] [Full Text] [Related]
48. Effect of angiotensin converting enzyme inhibition on blood pressure, plasma renin activity and plasma aldosterone in essential hypertension. Gavras H; Gavras I; Textor S; Volicer L; Brunner HR; Rucinska EJ J Clin Endocrinol Metab; 1978 Feb; 46(2):220-6. PubMed ID: 220274 [No Abstract] [Full Text] [Related]
49. Saralasin for diagnosis of renovascular hypertension. Med Lett Drugs Ther; 1982 Jan; 24(600):3-4. PubMed ID: 7054649 [No Abstract] [Full Text] [Related]
50. Continuous angiotensin II blockade throughout the acute phase of one-kidney hypertension in the dog. Watkins BE; Davis JO; Freeman RH; DeForrest JM; Stephens GA Circ Res; 1978 Jun; 42(6):813-21. PubMed ID: 657442 [No Abstract] [Full Text] [Related]
51. [Saralasin in subjects with low renin arterial hypertension]. Frisina N; Buemi M; Lasco A; Macrí I; Ciraolo O; Nicita Mauro V; Costa G Boll Soc Ital Biol Sper; 1980 Jul; 56(13):1367-73. PubMed ID: 7004464 [TBL] [Abstract][Full Text] [Related]
52. [Saralasin test, renal vein renin and unilateral kidney blood flow in renovascular hypertension]. Helber A; Hummerich W; Bönner G; Meurer KA; Moritz G Verh Dtsch Ges Kreislaufforsch; 1977; 43():208-9. PubMed ID: 613575 [No Abstract] [Full Text] [Related]
53. Angiotensin-converting enzyme inhibitors. Dipalma JR Am Fam Physician; 1980 Nov; 22(5):164-5. PubMed ID: 6158857 [No Abstract] [Full Text] [Related]
54. Central hypertensive actions of angiotensin. Vollmer R; Buckley JP; Solomon TA; Jandhyala BS Acta Physiol Lat Am; 1974; 24(5):582-6. PubMed ID: 4377510 [No Abstract] [Full Text] [Related]
55. [Differential diagnosis of hypertension using the angiotensin II antagonist saralasin]. Knauf H; Burmeister P; Büttner C; Hoppe-Seyler G; Schollmeyer P Verh Dtsch Ges Kreislaufforsch; 1977; 43():214-5. PubMed ID: 613578 [No Abstract] [Full Text] [Related]
56. Comparison between saralsin and converting enzyme inhibitor in hypertensive disease. Case DB; Wallace JM; Laragh JH Kidney Int Suppl; 1979 Mar; (9):S107-114. PubMed ID: 225598 [No Abstract] [Full Text] [Related]
57. Predictive value of angiotensin II antagonists in renovascular hypertension. Fouad FM; Gifford RW; Fighali S; Mujais SK; Novick AC; Bravo EL; Tarazi RC JAMA; 1983 Jan; 249(3):368-73. PubMed ID: 6336802 [TBL] [Abstract][Full Text] [Related]